PepGen (PEPG) Non Operating Income (2021 - 2026)
PepGen (PEPG) reported Non Operating Income of $1.2 million for Q1 2026, up 6.7% on a YoY basis from $1.1 million in Q1 2025, and down 15.56% sequentially from $1.4 million in Q4 2025.
PepGen (PEPG) Non Operating Income (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Non Operating Income data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 6.7% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (down 37.04% YoY), and the FY2025 full-year result was $4.0 million, down 43.9% from the prior year.
- Non Operating Income retreated to $1.2 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.1 million in Q2 2024 to a low of $67000.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income jumped 2885.29% in 2022 and sank 64.86% in 2025, its largest moves.
- Tracing PEPG's Non Operating Income over 5 years: stood at $1.6 million in 2022, then declined by 11.13% to $1.4 million in 2023, then advanced by 6.98% to $1.5 million in 2024, then dropped by 4.85% to $1.4 million in 2025, then slipped by 15.56% to $1.2 million in 2026.
- Business Quant data shows PEPG's Non Operating Income at $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $628000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | 628,000.00 |
| Jun 30, 2025 | 845,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.62 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Sep 30, 2022 | 947,000.00 |
| Jun 30, 2022 | 326,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | -34,000.00 |
| Jun 30, 2021 | -197,000.00 |